Our finding that loss of immune tolerance in myeloid S100A4+ DCs can mediate mAIP in mice may help to explain some pathogenic aspects of human AIP, an IgG4-related sclerosing disease. This evidence concerns the gene S100A4 and immunoglobulin G4-related sclerosing disease.